Pemigatinib

ATC L01EN02 · 10 markets · 32 records

Pemigatinib 10 markets · 32 records Forms

US 6 records · 3 strengths

  • 13.5 mgtabletPEMAZYREManufacturer: Lonza Tampa LLC also in AU·GB·CA +4
  • 9 mgtabletPEMAZYREManufacturer: Lonza Tampa LLC also in AU·GB·CA +4
  • 4.5 mgtabletPEMAZYREManufacturer: Lonza Tampa LLC also in AU·GB·CA +4

AU 4 records · 4 strengths

  • 13.5 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack also in US·GB·CA +4 unknown
  • 9 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack also in US·GB·CA +4 unknown
  • 4.5 mgtabletPEMAZYRE pemigatinib 9 mg tablet blister pack also in US·GB·CA +4 unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

GB 3 records · 3 strengths

CA 3 records · 3 strengths

SG 3 records · 3 strengths

ES 3 records · 3 strengths

TW 3 records · 3 strengths

HK 3 records · 1 strengths

    3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商

    FR 3 records · 3 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.